NYSE:CHE Chemed (CHE) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free CHE Stock Alerts $573.34 -44.61 (-7.22%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$561.00▼$593.3650-Day Range$583.43▼$650.7052-Week Range$492.84▼$654.62Volume260,708 shsAverage Volume79,776 shsMarket Capitalization$8.67 billionP/E Ratio31.99Dividend Yield0.28%Price Target$681.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Chemed alerts: Email Address Chemed MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside19.0% Upside$681.00 Price TargetShort InterestHealthy2.96% of Float Sold ShortDividend StrengthStrongBased on Four FactorsSustainability-0.33Upright™ Environmental ScoreNews Sentiment0.25Based on 15 Articles This WeekInsider TradingSelling Shares$10.18 M Sold Last QuarterProj. Earnings Growth9.28%From $21.99 to $24.03 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.76 out of 5 starsMedical Sector39th out of 907 stocksHome Health Care Services Industry2nd out of 8 stocks 2.5 Analyst's Opinion Consensus RatingChemed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageChemed has only been the subject of 2 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.96% of the float of Chemed has been sold short.Short Interest Ratio / Days to CoverChemed has a short interest ratio ("days to cover") of 5.5.Change versus previous monthShort interest in Chemed has recently decreased by 3.30%, indicating that investor sentiment is improving. Previous Next 3.3 Dividend Strength Dividend YieldChemed has a dividend yield of 0.26%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthChemed has been increasing its dividend for 15 years.Dividend CoverageThe dividend payout ratio of Chemed is 8.93%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Chemed will have a dividend payout ratio of 6.66% next year. This indicates that Chemed will be able to sustain or increase its dividend. Previous Next 4.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreChemed has received a 80.32% net impact score from Upright. Chemed seems to create the most significant positive value in categories "Taxes", "Jobs", and "Meaning & joy". The positive contribution in the "Meaning & joy" impact category is mostly driven by its "Private hospice care", "Private home care for the elderly", and "Property water damage restoration" products. See details.Environmental SustainabilityThe Environmental Impact score for Chemed is -0.33. Previous Next 1.8 News and Social Media Coverage News SentimentChemed has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.42 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 15 news articles for Chemed this week, compared to 5 articles on an average week.Search InterestOnly 5 people have searched for CHE on MarketBeat in the last 30 days. This is a decrease of -44% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Chemed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $10,184,531.00 in company stock.Percentage Held by InsidersOnly 3.32% of the stock of Chemed is held by insiders.Percentage Held by Institutions95.85% of the stock of Chemed is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Chemed are expected to grow by 9.28% in the coming year, from $21.99 to $24.03 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Chemed is 31.94, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 140.57.Price to Earnings Ratio vs. SectorThe P/E ratio of Chemed is 31.94, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 203.97.Price to Earnings Growth RatioChemed has a PEG Ratio of 2.47. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioChemed has a P/B Ratio of 7.78. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Chemed Stock (NYSE:CHE)Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Read More CHE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CHE Stock News HeadlinesApril 2, 2024 | insidertrades.comInsider Selling: Chemed Co. (NYSE:CHE) EVP Sells 2,000 Shares of StockApril 25, 2024 | msn.comCHE Stock Earnings: Chemed Misses EPS, Misses Revenue for Q1 2024April 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 24, 2024 | markets.businessinsider.comChemed Corp. Announces Increase In Q1 Income, but misses estimatesApril 24, 2024 | sfgate.comChemed: Q1 Earnings SnapshotApril 24, 2024 | businesswire.comChemed Reports First-Quarter 2024 ResultsApril 23, 2024 | msn.comChemed 2024 Earnings PreviewApril 23, 2024 | markets.businessinsider.comChemed earnings: here's what Wall Street expectsApril 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 21, 2024 | americanbankingnews.comCareRx (OTCMKTS:CHHHF) versus Chemed (NYSE:CHE) Critical ReviewApril 17, 2024 | finance.yahoo.comVITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and AlabamaApril 17, 2024 | businesswire.comVITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and AlabamaApril 17, 2024 | americanbankingnews.comChemed (CHE) Set to Announce Quarterly Earnings on WednesdayApril 9, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Chemed (CHE) and Alkermes (ALKS)April 3, 2024 | finance.yahoo.comChemed Corporation (CHE) Rose 13% in Q4April 1, 2024 | gurufocus.comChemed Corp Executive Vice President Spencer Lee Sells Company SharesApril 1, 2024 | finance.yahoo.comChemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25March 22, 2024 | finance.yahoo.comChemed Corp VP and Chief Legal Officer Brian Judkins Sells 11,158 SharesMarch 21, 2024 | finance.yahoo.comChemed Corporation's (NYSE:CHE) Stock Is Going Strong: Have Financials A Role To Play?March 16, 2024 | finance.yahoo.comCHE Apr 2024 670.000 callMarch 16, 2024 | finance.yahoo.comCHE Apr 2024 590.000 putMarch 13, 2024 | markets.businessinsider.comChemed's Subsidiary To Purchase Hospice Assets Of Covenant Care For $85 Mln In Florida, AlabamaMarch 13, 2024 | bizjournals.comChemed's Vitas Healthcare plans $85M acquisition to expand Florida footprintMarch 13, 2024 | finance.yahoo.comVITAS To Buy Hospice Assets of Covenant Care in Florida and AlabamaMarch 12, 2024 | msn.comWhen is Passover? What you need to know ahead of the Jewish holidayMarch 8, 2024 | businesswire.comChemed Corporation to Present at the Oppenheimer 34th Annual Healthcare ConferenceMarch 1, 2024 | finance.yahoo.comChemed Corporation (NYSE:CHE) Just Released Its Annual Results And Analysts Are Updating Their EstimatesSee More Headlines Receive CHE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 3/15 Dividend2/23/2024Dividend Payable3/15/2024Last Earnings4/24/2024Today4/25/2024Next Earnings (Estimated)7/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Home health care services Sub-IndustryHealth Care Services Current SymbolNYSE:CHE CUSIP16359R10 CIK19584 Webwww.chemed.com Phone(513) 762-6690Fax513-762-6590Employees15,087Year Founded1970Price Target and Rating Average Stock Price Target$681.00 High Stock Price Target$712.00 Low Stock Price Target$650.00 Potential Upside/Downside+18.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$17.92 Trailing P/E Ratio32.18 Forward P/E Ratio26.23 P/E Growth2.47Net Income$272.51 million Net Margins12.03% Pretax Margin15.47% Return on Equity32.29% Return on Assets20.74% Debt Debt-to-Equity RatioN/A Current Ratio1.61 Quick Ratio1.57 Sales & Book Value Annual Sales$2.26 billion Price / Sales3.85 Cash Flow$22.98 per share Price / Cash Flow25.10 Book Value$73.55 per share Price / Book7.84Miscellaneous Outstanding Shares15,120,000Free Float14,615,000Market Cap$8.72 billion OptionableOptionable Beta0.42 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Kevin J. McNamara (Age 70)CEO, President & Director Comp: $5.84MMr. Michael D. Witzeman CPA (Age 53)MBA, VP, Controller, Principal Accounting Officer & CFO Comp: $1.15MMr. Spencer S. Lee (Age 68)Executive Vice President Comp: $1.65MMr. Thomas C. Hutton (Age 73)VP & Director Mr. Nicholas Michael Westfall (Age 45)Executive Vice President Comp: $2.5MMs. Lisa A. ReinhardVP, Chief Administrative Officer & SecretarySherri WarnerDirector of Investor RelationsMr. Brian C. Judkins (Age 43)VP, Secretary & Chief Legal Officer More ExecutivesKey CompetitorsAmedisysNASDAQ:AMEDOption Care HealthNASDAQ:OPCHHenry ScheinNASDAQ:HSICQiagenNYSE:QGENRepligenNASDAQ:RGENView All CompetitorsInsiders & InstitutionsCENTRAL TRUST CoSold 24 shares on 4/24/2024Ownership: 0.001%North Point Portfolio Managers Corp OHSold 92 shares on 4/23/2024Ownership: 0.111%Louisiana State Employees Retirement SystemBought 100 shares on 4/23/2024Ownership: 0.028%Iowa State BankSold 50 shares on 4/23/2024Ownership: 0.006%TrueWealth Advisors LLCSold 245 shares on 4/23/2024Ownership: 0.003%View All Insider TransactionsView All Institutional Transactions CHE Stock Analysis - Frequently Asked Questions Should I buy or sell Chemed stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CHE shares. View CHE analyst ratings or view top-rated stocks. What is Chemed's stock price target for 2024? 2 brokerages have issued 12 month price targets for Chemed's shares. Their CHE share price targets range from $650.00 to $712.00. On average, they expect the company's stock price to reach $681.00 in the next twelve months. This suggests a possible upside of 19.0% from the stock's current price. View analysts price targets for CHE or view top-rated stocks among Wall Street analysts. How have CHE shares performed in 2024? Chemed's stock was trading at $584.75 at the beginning of the year. Since then, CHE shares have decreased by 2.1% and is now trading at $572.42. View the best growth stocks for 2024 here. When is Chemed's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 24th 2024. View our CHE earnings forecast. How were Chemed's earnings last quarter? Chemed Co. (NYSE:CHE) issued its quarterly earnings results on Wednesday, April, 24th. The company reported $4.68 EPS for the quarter, missing the consensus estimate of $5.09 by $0.41. The business earned $589.23 million during the quarter, compared to analysts' expectations of $587.18 million. Chemed had a trailing twelve-month return on equity of 32.29% and a net margin of 12.03%. How often does Chemed pay dividends? What is the dividend yield for Chemed? Chemed declared a quarterly dividend on Friday, February 16th. Shareholders of record on Monday, February 26th will be given a dividend of $0.40 per share on Friday, March 15th. This represents a $1.60 annualized dividend and a yield of 0.28%. The ex-dividend date of this dividend is Friday, February 23rd. Read our dividend analysis for CHE. Is Chemed a good dividend stock? Chemed (NYSE:CHE) pays an annual dividend of $1.60 per share and currently has a dividend yield of 0.26%. The company has been increasing its dividend for 15 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 8.93%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CHE will have a dividend payout ratio of 6.66% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for CHE. What ETFs hold Chemed's stock? ETFs with the largest weight of Chemed (NYSE:CHE) stock in their portfolio include Formidable Fortress ETF (KONG), VictoryShares THB Mid Cap ESG ETF (MDCP), Inspire Faithward Mid Cap Momentum ETF (GLRY), First Trust Dorsey Wright Momentum & Low Volatility ETF (DVOL), Opus Small Cap Value Plus ETF (OSCV), ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM), FIS Biblically Responsible Risk Managed ETF (PRAY) and ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL). What guidance has Chemed issued on next quarter's earnings? Chemed updated its FY 2024 earnings guidance on Wednesday, April, 24th. The company provided earnings per share guidance of 23.300-23.700 for the period, compared to the consensus earnings per share estimate of 23.520. The company issued revenue guidance of -. What is Kevin J. McNamara's approval rating as Chemed's CEO? 1 employees have rated Chemed Chief Executive Officer Kevin J. McNamara on Glassdoor.com. Kevin J. McNamara has an approval rating of 100% among the company's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Chemed own? Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX). Who are Chemed's major shareholders? Chemed's stock is owned by a variety of institutional and retail investors. Top institutional investors include Raymond James & Associates (0.48%), Los Angeles Capital Management LLC (0.28%), North Point Portfolio Managers Corp OH (0.11%), Capital Insight Partners LLC (0.07%), Amalgamated Bank (0.06%) and Sugarloaf Wealth Management LLC (0.04%). Insiders that own company stock include Brian C Judkins, David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee and Thomas P Rice. View institutional ownership trends. How do I buy shares of Chemed? Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:CHE) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemed Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
